Safety and Efficacy of Peri-Procedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Undergoing Percutaneous Coronary Intervention (From the Intermountain Heart Institute STAIR Observational Registry)

Glycoprotein IIb/IIIa inhibitors, used as a standard intravenous bolus followed by a prolonged infusion for 12-18 hours, reduces ischemic complications during percutaneous coronary interventions (PCI) but often at a cost of increased bleeding. Today, when dual oral antiplatelet therapy is routine, heparin use plus short-term (bolus alone or with a

Source: The American Journal of Cardiology - March 14, 2019 Category: Cardiology Authors: Joseph B. Muhlestein, Ian S. Hackett, Heidi T. May, Tami L. Bair, Viet T. Le, Jeffrey L. Anderson, Brian Whisenant, Kirk U. Knowlton, Donald L. Lapp é Source Type: research